SCHEMBL25299754

SCHEMBL25299754

Cc1c(Br)ccnc1C#N

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 1/20 0.33
PIM1 P11309 1/20 0.33
ACVR1 Q04771 1/20 0.33
PLCG1 P19174 1/20 0.32
ERBB2 P04626 2/20 0.31
MAPT P10636 1/20 0.31
PRKCI P41743 1/20 0.31
NOS3 P29474 1/20 0.30
NOS2 P35228 1/20 0.30
NPC1 O15118 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30
HPGD P15428 1/20 0.30
RECQL P46063 1/20 0.30
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
CHEK1 O14757 1/20 0.30
ABL1 P00519 1/20 0.30
PDGFRB P09619 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6437896 0.78 ERBB2 (0.32) PLCG1ERBB2MAPTPRKCIALDH1A1
SCHEMBL6170131 0.78 NOS3 (0.46) PLCG1ERBB2MAPTNOS3NOS2
SCHEMBL17570530 0.77 TSHR (0.37) PIM1PLCG1ERBB2MAPTNOS3
SCHEMBL17416894 0.75 MEN1 (0.39) PLCG1ERBB2MAPTPRKCIALDH1A1
SCHEMBL30527748 0.75 MEN1 (0.39) PLCG1ERBB2MAPTPRKCIALDH1A1
SCHEMBL14842294 0.75 TDO2 (0.33) ERBB2PRKCI
SCHEMBL3360364 0.75 KDM4E (0.36) ERBB2PRKCIALDH1A1POLBLRRK2
SCHEMBL4385912 0.75 PLCG1 (0.35) PLCG1ERBB2MAPTNOS3NOS2
SCHEMBL1841305 0.75 CCR1 (0.35) NTRK1PIM1ACVR1PLCG1ERBB2
SCHEMBL2671146 0.75 ALDH1A1 (0.40) NTRK1PIM1ACVR1PLCG1ERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115974872-B Azacyclic derivatives, pharmaceutical compositions thereof and uses thereof 南方科技大学 2025-05-02 CN disclosed
WO-2023134713-A1 FUSED AZAHETEROCYCLIC DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF 南方科技大学 2023-07-20 WO disclosed
CN-115974872-A Aza-and-ring derivatives, pharmaceutical compositions thereof and uses thereof 南方科技大学 2023-04-18 CN disclosed
CN-110139862-A It can be used as the bicyclic heterocycles derivative of ROMK channel inhibitor being substituted 百时美施贵宝公司 2019-08-16 CN disclosed
CN-107001342-A Novel compounds 葛兰素史密斯克莱知识产权发展有限公司 2017-08-01 CN disclosed
CN-104710420-B Azabicyclic formula compound or its salt, containing its medicine, compositions and application 大鹏药品工业株式会社 2016-07-27 CN disclosed
CN-103492385-B Be used for the treatment of the noval chemical compound of degenerative disease and inflammatory disease GALAPAGOS N.V. (BE) 2016-05-11 CN disclosed
CN-103492386-B Novel compounds useful for the treatment of degenerative and inflammatory diseases GALAPAGOS N.V. (BE) 2016-03-09 CN disclosed
CN-103596953-A Pyridonaphthyridine PI3K/mTOR dual inhibitors and preparation and use thereof KBP BIOSCIENCES CO LTD 2014-02-19 CN disclosed
CN-103492386-A Novel compounds useful for the treatment of degenerative and inflammatory diseases GALAPAGOS NV 2014-01-01 CN disclosed
CN-103492385-A Novel compound useful for the treatment of degenerative and inflammatory diseases GALAPAGOS NV 2014-01-01 CN disclosed
CN-1433413-A Oxazolidinone derivatives and process for their preparation DONG A PHARM CO LTD (KR) 2003-07-30 CN disclosed